Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-23 Purchase |
2020-06-25 7:40 pm |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
250,000 | $20 | $5,000,000 | 3,419,451 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 7:09 pm |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director |
250,000 | $20 | $5,000,000 | 3,419,451 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 6:46 pm |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
250,000 | $20 | $5,000,000 | 3,419,451 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 6:00 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
5,000 | $20 | $100,000 | 153,466 (Indirect Direct) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:59 pm |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
5,000 | $20 | $100,000 | 5,000 (Direct) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:58 pm |
Repare Therapeutics Inc. | RPTX | SCHAFER CAROL Director |
8,000 | $20 | $160,000 | 8,000 (Direct) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:57 pm |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
4,800 | $20 | $96,000 | 4,800 (Direct) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:55 pm |
Repare Therapeutics Inc. | RPTX | RHOADS ANN D Director |
4,000 | $20 | $80,000 | 4,000 (Direct) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:54 pm |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
774,200 | $20 | $15,484,000 | 99,200 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:53 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
774,200 | $20 | $15,484,000 | 99,200 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 4:33 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
500,000 | $20 | $10,000,000 | 5,392,109 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 4:32 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
250,000 | $20 | $5,000,000 | 3,003,772 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 4:31 pm |
Repare Therapeutics Inc. | RPTX | MPM BioVentures 2014 L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 (B) L.P. MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC EVNIN LUKE 10% Owner |
250,000 | $20 | $5,000,000 | 3,003,772 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-23 Conversion |
2020-06-25 7:40 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
6,245,349 | $0 | 3,419,451 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 7:09 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director |
6,245,349 | $0 | 3,419,451 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 6:46 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
6,245,349 | $0 | 3,419,451 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 5:54 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
2,601,325 | $0 | 99,200 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 5:53 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
2,601,325 | $0 | 99,200 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 5:04 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Redmile Group LLC Green Jeremy 10% Owner |
1,586,174 | $0 | 1,586,174 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 4:33 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
4,892,109 | $0 | 5,392,109 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 4:32 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
2,753,772 | $0 | 3,003,772 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 4:31 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | MPM BioVentures 2014 L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 (B) L.P. MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC EVNIN LUKE 10% Owner |
2,753,772 | $0 | 3,003,772 (Indirect) |
View |
Ownership |
2020-06-19 9:07 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Redmile Group LLC Green Jeremy 10% Owner |
0 | $0 | 1,586,174 (Indirect) |
View |
| 2020-06-18 Option Award |
2020-06-19 08:09 am |
N/A 2030-06-18 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
41,240 | $0 | 41,240 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 08:07 am |
N/A 2030-06-18 |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
354,668 | $0 | 354,668 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 08:06 am |
N/A 2030-06-18 |
Repare Therapeutics Inc. | RPTX | RHOADS ANN D Director |
38,907 | $0 | 38,907 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 08:05 am |
N/A 2030-06-18 |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
41,240 | $0 | 41,240 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 08:04 am |
N/A 2030-06-18 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
41,240 | $0 | 41,240 (Direct) |
View |
Ownership |
2020-06-18 9:48 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
0 | $0 | 419,827 (Direct) |
View |
Ownership |
2020-06-18 9:45 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
0 | $0 | 6,987,679 (Indirect) |
View |
Ownership |
2020-06-18 9:44 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Venture Capital V L.P. Versant Ventures V (Canada) L.P. Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner |
0 | $0 | 6,987,679 (Indirect) |
View |
Ownership |
2020-06-18 9:40 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
0 | $0 | 1,195,974 (Indirect) |
View |
Ownership |
2020-06-18 9:37 pm |
N/A 2029-03-29 |
Repare Therapeutics Inc. | RPTX | SCHAFER CAROL Director |
0 | $0 | 70,933 (Direct) |
View |
Ownership |
2020-06-18 9:34 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner |
0 | $0 | 2,601,325 (Indirect) |
View |
Ownership |
2020-06-18 9:32 pm |
N/A 2027-06-22 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
0 | $0 | 90,728 (Direct) |
View |
Ownership |
2020-06-18 9:31 pm |
N/A 2029-11-21 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
0 | $0 | 70,933 (Direct) |
View |
Ownership |
2020-06-18 9:29 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
0 | $0 | 305,179 (Direct) |
View |
Ownership |
2020-06-18 9:28 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
0 | $0 | 4,892,109 (Indirect) |
View |
Ownership |
2020-06-18 9:28 pm |
N/A 2029-10-28 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
0 | $0 | 325,800 (Direct) |
View |
Ownership |
2020-06-18 9:27 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Foley Todd Director 10% Owner |
0 | $0 | 2,753,772 (Indirect) |
View |
Ownership |
2020-06-18 9:26 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | MPM BioVentures 2014 L.P. EVNIN LUKE MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC 10% Owner |
0 | $0 | 2,753,772 (Indirect) |
View |
Ownership |
2020-06-18 9:25 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director |
0 | $0 | 6,987,679 (Indirect) |
View |
Ownership |
2020-06-18 9:23 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Bonita David P Director 10% Owner |
0 | $0 | 2,601,325 (Indirect) |
View |